TERT peptide vaccines such as INO-1400 (NCT02960594—solid tumors), GV1001 (NCT04032067—Benign Prostatic Hyperplasia), UCPVax (NCT04263051—non-small cell lung cancer), and GX301 (97) are currently being tested in clinical trials for cancer therapy. Here, TERT is linked to cancer.